Tufts Medical Center NEW Drug Development ParadIGmS (NEWDIGS) is an international “think and do tank” dedicated to delivering more value faster to patients, in ways that work for all stakeholders. NEWDIGS designs, evaluates, and initiates advancements that are too complex and cross-cutting to be addressed by a single organization or market sector. Its members include global leaders from patient advocacy, payer organizations, biopharmaceuti-cal companies, regulatory agencies, clinical care, academic research, and investment firms. For more information, visit https://newdigs.tuftsmedicalcenter.org.
